Cytel

Cytel is a global leader in advanced analytics and software for clinical development, operating as a hybrid services and technology company. It provides end-to-end solutions spanning trial design, biometrics, real-world evidence, and market access, supported by proprietary software like East for trial design and Xact for trial implementation. With deep expertise in complex adaptive and Bayesian trial designs, Cytel serves as a strategic partner to life science companies aiming to increase the probability of clinical success and operational efficiency. The company is privately held and headquartered in Basel, Switzerland.

Proprietary software suites including East® for adaptive trial design/simulation, Xact® suite (including StatXact®) for trial implementation/analysis, and LiveSLR® for systematic literature reviews, integrated with advanced data science and statistical consulting services.

Cytel operates in a competitive market competing against large, full-service global CROs (e.g., IQVIA, Parexel) on services and against specialized clinical trial software vendors (e.g., Medidata, a Dassault Systèmes company) on technology. Its key differentiation is its deep, integrated expertise in advanced statistical methodologies and adaptive designs, combined with proprietary software that operationalizes these methods, creating a hybrid model that pure-play CROs or software firms find difficult to replicate.